Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study

OBJECTIVE: To evaluate the effects of the T-cell costimulation blocker abatacept on anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) in early rheumatoid arthritis (RA), and associations between changes in serological status and clinical response. METHODS: Post hoc analysis of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Jansen, Diahann T S L, Emery, Paul, Smolen, Josef S, Westhovens, Rene, Le Bars, Manuela, Connolly, Sean E, Ye, June, Toes, René E M, Huizinga, Tom W J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892779/
https://ncbi.nlm.nih.gov/pubmed/29657830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000564
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars